Skip to content

E.J.L. ExAct: what changed

What changed

E.J.L. ExAct

BE 0846.380.626
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€2,218
2024 · -€5,900+€3,682
Equity
€59,234
2024 · €61,452-€2,218
Cash
€242
2024 · €342-€100
Balance sheet total
€59,234
2024 · €61,978-€2,744

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€2,644

    down €2,644 (-4.3%), from €61,636 to €58,992

    of which Other amounts receivable: -€2,644

Equity and liabilities
  • Profit (loss) carried forward -€2,218

    down €2,218 (-6.3%), from -€35,344 to -€37,562

Income statement
  • Gross operating margin +€3,224

    up €3,224 (+40.2%), from -€8,014 to -€4,790

  • Other operating charges -€390

    down €390 (-48.1%), from €811 to €421

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€5,900
Gross operating margin +€3,224
Other operating charges +€390
Financial income +€28
Financial charges +€40
Result 2025 -€2,218
raises the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€100
Investment €0
Financing €0
Cash 2024 €342
Net result for the year -€2,218
Receivables within one year +€2,644
Trade debts -€526
Cash 2025 €242
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €61,978 €59,234 -€2,744 -4.4%
Tangible fixed assets 22/27 €0 - =
Current assets 29/58 €61,978 €59,234 -€2,744 -4.4%
Amounts receivable within one year 40/41 €61,636 €58,992 -€2,644 -4.3%
Trade receivables 40 €0 - =
Other amounts receivable 41 €61,636 €58,992 -€2,644 -4.3%
Cash at bank and in hand 54/58 €342 €242 -€100 -29.3%
Total equity and liabilities 10/49 €61,978 €59,234 -€2,744 -4.4%
Equity 10/15 €61,452 €59,234 -€2,218 -3.6%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €84,396 €84,396 = 0.0%
Non-distributable reserves 130/1 €1,860 - -€1,860
Reserves not available under the articles 1311 €1,860 - -€1,860
Distributable reserves 133 €82,536 €84,396 +€1,860 +2.3%
Profit (loss) carried forward 14 -€35,344 -€37,562 -€2,218 -6.3%
Amounts payable 17/49 €526 - -€526
Amounts payable within one year 42/48 €526 - -€526
Trade debts 44 €526 - -€526
Suppliers 440/4 €526 - -€526
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €0 - =
Other operating charges 640/8 €811 €421 -€390 -48.1%
Gross operating margin 9900 -€8,014 -€4,790 +€3,224 +40.2%
Operating profit (loss) 9901 -€8,825 -€5,211 +€3,614 +41.0%
Financial income 75/76B €3,110 €3,138 +€28 +0.9%
Recurring financial income 75 €3,110 €3,138 +€28 +0.9%
Financial charges 65/66B €185 €145 -€40 -21.8%
Recurring financial charges 65 €185 €145 -€40 -21.8%
Profit (loss) for the period before taxes 9903 -€5,900 -€2,218 +€3,682 +62.4%
Profit (loss) for the period 9904 -€5,900 -€2,218 +€3,682 +62.4%
Profit (loss) for the period to be appropriated 9905 -€5,900 -€2,218 +€3,682 +62.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.